Status:
COMPLETED
Prognosis of Coronavirus Disease 2019 (COVID-19) Patients Receiving Receiving Antihypertensives
Lead Sponsor:
Hakeam Abdulaziz Hakeam
Collaborating Sponsors:
Buraidah Central Hospital
King Khalid University Hospital
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
Coronavirus disease 2019 (COVID-19) ,caused by the newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virus, has shown substantial global spread affecting over 2 million peo...
Detailed Description
Design and Patients: this is a prospective, observational multi-center study, to be conducted at King Faisal Specialist Hospital and Research Centre (KFSH \& RC), Riyadh, Saudi Arabia as a primary cen...
Eligibility Criteria
Inclusion
- Criteria Include patients infected with the COVID19 (via positive PCR) aged ≥ 18 years with one of the following:
- Hypertension
- Coronary artery disease
- Heart failure
- Diabetes mellitus.
Exclusion
- Pregnancy
Key Trial Info
Start Date :
May 10 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2020
Estimated Enrollment :
314 Patients enrolled
Trial Details
Trial ID
NCT04357535
Start Date
May 10 2020
End Date
August 1 2020
Last Update
August 4 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
King Faisal Specialist Hospital & Research Centre
Riyadh, Saudi Arabia, 11211